These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33786990)

  • 61. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
    Gautret P; Lagier JC; Honoré S; Hoang VT; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106242. PubMed ID: 33408033
    [No Abstract]   [Full Text] [Related]  

  • 62. Global COVID-19 pandemic and reporting behavior - An analysis of the Food and Drug Administration adverse events reporting system.
    Dörks M; Jobski K; Hoffmann F; Douros A
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):707-715. PubMed ID: 33650210
    [TBL] [Abstract][Full Text] [Related]  

  • 63. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association of the MedWise Risk Score with health care outcomes.
    Michaud V; Smith MK; Bikmetov R; Dow P; Johnson J; Stein A; Finnel S; Jin H; Turgeon J
    Am J Manag Care; 2021 Sep; 27(16 Suppl):S280-S291. PubMed ID: 34529367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection.
    El Nekidy WS; Almuti K; ElRefaei H; Atallah B; Mohammad LM; AlMahmeed W; Badr M; Abdallah K; Hamed F; Mallat J
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484211069479. PubMed ID: 35006023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.
    Bérard A; Sheehy O; Zhao JP; Vinet E; Quach C; Kassai B; Bernatsky S
    PLoS One; 2021; 16(5):e0251746. PubMed ID: 34010282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    J Am Coll Cardiol; 2020 May; 75(20):2623-2624. PubMed ID: 32283123
    [No Abstract]   [Full Text] [Related]  

  • 69. QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.
    Minguito-Carazo C; Echarte-Morales J; Benito-González T; Del Castillo-García S; Rodríguez-Santamarta M; Sánchez-Muñoz E; Maniega CG; García-Bergel R; Menéndez-Suárez P; Prieto-González S; Palacios-Echavarren C; Borrego-Rodríguez J; Flores-Vergara G; Iglesias-Garriz I; Fernández-Vázquez F
    Glob Heart; 2021 Jun; 16(1):42. PubMed ID: 34211828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
    Gautret P; Lagier JC; Honoré S; Hoang VT; Colson P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106243. PubMed ID: 33408014
    [No Abstract]   [Full Text] [Related]  

  • 71. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system.
    Orogun L; Chyou TY; Nishtala PS
    Int J Risk Saf Med; 2023; 34(2):87-99. PubMed ID: 37154187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States.
    Lu M; Oladapo A; Wu Y; Farahbakhshian S; Ewenstein B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):175-185. PubMed ID: 33307935
    [No Abstract]   [Full Text] [Related]  

  • 74. Safety perspectives on presently considered drugs for the treatment of COVID-19.
    Penman SL; Kiy RT; Jensen RL; Beoku-Betts C; Alfirevic A; Back D; Khoo SH; Owen A; Pirmohamed M; Park BK; Meng X; Goldring CE; Chadwick AE
    Br J Pharmacol; 2020 Oct; 177(19):4353-4374. PubMed ID: 32681537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System.
    Fusaroli M; Raschi E; Gatti M; De Ponti F; Poluzzi E
    Front Pharmacol; 2021; 12():740707. PubMed ID: 34955821
    [No Abstract]   [Full Text] [Related]  

  • 76. Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic.
    Cracowski JL; Molimard M; Richard V; Roustit M; Khouri C
    Expert Opin Drug Saf; 2024 Aug; 23(8):959-967. PubMed ID: 38898690
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case-Crossover Design.
    Shi Y; Eadon MT; Chen Y; Sun A; Yang Y; Chiang C; Donneyong M; Su J; Zhang P
    Stat Med; 2024 Sep; ():. PubMed ID: 39299911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Population Data-Driven Formulation of a COVID-19 Therapeutic.
    Campbell HR; Cecil R; Lodder RA
    medRxiv; 2020 Jul; ():. PubMed ID: 32743601
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.